Peng Liang

Peng Liang

Net worth: 53 M $ as of 2026-05-30

65 year
Consumer Services
Health Technology
Commercial Services

Profile

Peng Liang is the founder of Sichuan Clover Biopharmaceuticals, Inc, founded in 2007.
Dr. Liang was the founder of GenHunter Corp., founded in 1992, and served as President.
Dr. Liang is currently Chairman at Clover Biopharmaceuticals Ltd. since 2018.
Dr. Liang is currently Chairman at Zhejiang Clover Biopharmaceutical, Inc. since 2016.
Dr. Liang is currently Director at Clover Biopharmaceuticals AUS Pty Ltd. since 2017.
Dr. Liang is currently Director at Clover Biopharmaceuticals Hong Kong Ltd. since 2018.
Dr. Liang is currently President & Treasurer at Clover Biopharmaceuticals USA, Inc. since 2020.
Dr. Liang was Associate Professor at Vanderbilt University from 2008 to 2009.
Dr. Liang completed an undergraduate degree at Peking University in 1982.
Dr. Liang earned a doctorate from the University of Illinois in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-26 212,023,174 ( 16.33% ) 53 M $ 2026-05-30

Peng Liang active positions

CompaniesPositionStart
CLOVER BIOPHARMACEUTICALS, LTD. Chairman 2018-10-30
Clover Biopharmaceuticals Aus Pty Ltd.
Director/Board Member 2017-05-31
President 2020-03-31
Zhejiang Clover Biopharmaceutical, Inc.
Chairman 2016-07-31
Clover Biopharmaceuticals Hong Kong Ltd.
Director/Board Member 2018-10-31

Former positions of Peng Liang

CompaniesPositionEnd
Corporate Officer/Principal 2009-05-31
Founder -
Founder -
See the detail of Peng Liang's experience

Training of Peng Liang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

99

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Zhejiang Clover Biopharmaceutical, Inc.

Clover Biopharmaceuticals Aus Pty Ltd.

Clover Biopharmaceuticals Hong Kong Ltd.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!